Varicella Vaccine | Shim Clinic, Singapore

Varicella Vaccine | Shim Clinic, Singapore: Live varicella virus vaccine jab/shot/injection schedule, to vaccinate against the Varicella zoster virus (VZV) / Human herpes virus type 3, to immunise against chickenpox clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Various formulations of the live attenuated vaccine, based on the so-called Oka strain of VZV, are in use. From both a logistic and an epidemiological point of view, the optimal age for varicella vaccination is 12–24 months. In some countries, one dose of the vaccine is considered sufficient, regardless of age. In the United States, two doses, 4–8 weeks apart, are recommended for adolescents and adults. In a few cases (<5%), vaccinees experience a mild varicella-like disease with rash within 4 weeks. Contraindications to varicella vaccine are pregnancy (because of a theoretical risk to the fetus; pregnancy should be avoided for 4 weeks following vaccination), ongoing severe illness, a history of anaphylactic reactions to any component of the vaccine, and immunosuppression.

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Live attenuated
MMR vaccine			≥12m	1		$70/=
Measles vaccine	Measles virus	Measles
Mumps vaccine	Mumps virus	Mumps
Rubella vaccine	Rubella virus	Rubella
Varilrix™ Varicella vaccine Chickenpox vaccine	Varicella zoster virus HHV-3	Varicella Chickenpox	12m-12y	1		$121/=
Varilrix™ Varicella vaccine Chickenpox vaccine		Varicella Chickenpox	≥13y	2	6-10w interval	$121/=
Zostavax™ Herpes zoster vaccine Shingles vaccine		Herpes zoster Shingles	≥50y	1		$400/=
Stamaril® Yellow fever vaccine	Yellow fever virus	Yellow fever	9m-59y	1	10 yearly	$250/=
Inactivated / Whole / Viral & Bacterial
Ixiaro® Japanese encephalitis vaccine JE vaccine	Japanese encephalitis virus	Japanese encephalitis	≥17y	2	2nd: 28d after 1st	$386/=
Ixiaro® Japanese encephalitis vaccine JE vaccine	Japanese encephalitis virus	Japanese encephalitis	≥17y	1	Booster: 12-24m after 2nd	$386/=
Dukoral® Cholera vaccine	Vibrio cholerae	Cholera	2-6y	3	1-6w interval	$113/=
			2-6y	1	Booster: 6m after 3rd
			≥6y	2	1-6w interval
			≥6y	1	Booster: 2y after 2nd
Inactivated / Fractional / Protein
Intanza™ Influenza vaccine	Influenza virus	Influenza	18-59y	1	1 yearly	$30/=
Fluarix™ Influenza vaccine	Influenza virus	Influenza	6-36m	½	1 yearly	$30/=
Fluarix™ Influenza vaccine	Influenza virus	Influenza	>3y	1	1 yearly	$30/=
Tetavax Tetanus vaccine	Clostridium tetani	Tetanus	adults	3	1-2m interval 3rd @ 6-12m after 2nd	$30/=
Tetavax Tetanus vaccine	Clostridium tetani	Tetanus	booster	1	10 yearly	$30/=
Boostrix® Tdap vaccine DPT vaccine DTP vaccine			≥4y	1	<10 yearly	$70/=
Diphtheria vaccine	Corynebacterium diphtheriae	Diphtheria
Tetanus vaccine	Clostridium tetani	Tetanus
Pertussis vaccine Whooping cough vaccine	Bordetella pertussis	Pertussis Whooping cough
Inactivated / Fractional / Polysaccharide / Pure
Typhim Vi® Typhoid vaccine	Salmonella typhi	Typhoid fever	>5y	1	3 yearly	$40/=
Mencevax® ACWY MPSV4 Meningococcal Polysaccharide vaccine MPSV Meningococcal Meningitis vaccine Meningococcal vaccine Meningitis vaccine	Neisseria meningitidis types A, C, W-135 and Y	Meningococcal meningitis	>2y	1		$80/=
Inactivated / Fractional / Polysaccharide / Conjugate
Menactra® MCV4 Meningococcal conjugate vaccine MCV Meningococcal Meningitis vaccine Meningococcal vaccine Meningitis vaccine	Neisseria meningitidis types A, C, W-135 and Y	Meningococcal meningitis	2-55y	1		$220/=
Prevenar 13® (SG) / Prevnar 13® (US) PCV13 Pneumococcal conjugate vaccine PCV Pneumococcal Pneumonia vaccine Pneumococcal vaccine Pneumonia vaccine	Streptococcus pneumoniae types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F	Pneumococcal infection	6w-6m	4	1m interval 4th @ 12-15m	$274/=
			7-11m	2	1m interval
			12-23m	2	2m interval
			2-5y	1
			≥50y	1

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Havrix™ 1440 Adult Hepatitis A vaccine Hepatitis vaccine	Hepatitis A virus	Hepatitis A	≥19y	2	m 0 & 6-12	$90/=
Twinrix® Hepatitis vaccine	Hepatitis A virus Hepatitis B virus	Hepatitis A Hepatitis B	1-15y	2	m 0, 6-12	$120/=
			≥16y	3	m 0, 1, 6
			≥16y	4	d 0, 7, 21 & m 12
Inactivated / Fractional / Protein / Subunit / Recombinant
Engerix™-B 20 μg Hepatitis B vaccine Hepatitis vaccine	Hepatitis B virus	Hepatitis B	11-15y	2	m 0, & 6	$50/=
			≥20y	3	m 0, 1, & 6
			≥20y	4	m 0, 1, 2, & 12 or d 0, 7, 21 & m 12
Gardasil® HPV vaccine	HPV types 6, 11, 16, & 18	Genital warts Cervical cancer	9-26y	3	m 0, 2, & 6 or m 0, 1, & 4	$195/=
Cervarix® HPV vaccine	HPV types 16, & 18 (31, 33, & 45)		10-25y	3	m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12	$195/=
V503 HPV vaccine	HPV types 6, 11, 16, 18, 31, 33, 45, 52, & 58			3	m 0, 2, & 6 or m 0, 1, & 4	$???/=

Vaccination against	Birth	1 month	3 months	4 months	5 months	12 months	15 months	18 months	6-7 years^	10-11 years^^
Tuberculosis	BCG
Hepatitis B	HepB (D1)	HepB (D2)			HepB (D3)#
Diphtheria, Tetanus, Pertussis			DTaP (D1)	DTaP (D2)	DTaP (D3)			DTaP (B1)		Tdap (B2)
Poliovirus			OPV (D1)	OPV (D2)	OPV (D3)			OPV (B1)	OPV (B2)	OPV (B3)
Measles, Mumps, Rubella						MMR (D1)	MMR (D2)##
Pneumococcal Disease			PCV (D1)		PCV (D2)	PCV (B1)
Human Papillomavirus		Recommended for females 9 to 26 years; three doses are required at intervals of 0, 2, 6 months
Influenza		Recommended annually for all children aged 6 months to <5 years and children aged 6 months to <18 years in high-risk groups

Notes:
BCG	Bacillus Calmette-Guérin
HepB	Hepatitis B vaccine
DTaP	Paediatric diphtheria and tetanus toxoid and acellular pertussis vaccine
Tdap	Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
MMR	Measles, mumps, and rubella vaccine
OPV	Oral polio vaccine
PCV	Pneumococcal conjugate vaccine
D1/D2/D3	1st dose, 2nd dose, 3rd dose
B1/B2/B3	1st booster, 2nd booster, 3rd booster
^	Primary 1
^^	Primary 5


#	3rd dose of HepB can be given with the 3rd dose of DTaP and OPV for the convenience of parents.
##	2nd dose of MMR can be given between 15-18 months

Well: Depression May Stifle Shingles Vaccine Response
Fri, 22 Feb 2013 16:20:29 +0100 | NYT Health
Adults with untreated depression who received the shingles vaccine mounted a relatively weak immune response compared with their healthy age-matched peers, or to those taking antidepressants. (Source: NYT Health)

UCLA study suggests link between untreated depression, response to shingles vaccine
Tue, 19 Feb 2013 05:00:00 +0100 | EurekAlert! - Social and Behavioral Science
(University of California - Los Angeles) More evidence for the mind-body connection -- a new UCLA study suggests a link between untreated depression and response to the shingles vaccine. The bigger issue -- can one's mental state impact how effective any vaccine is? (Source: EurekAlert! - Social and Behavioral Science)

Depression reduces efficacy of shingles vaccine
Sat, 16 Feb 2013 08:20:10 +0100 | MedWire News - Dermatology
Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression. (Source: MedWire News - Dermatology)

Depression reduces efficacy of shingles vaccine
Fri, 15 Feb 2013 00:00:00 +0100 | MedWire News - Psychiatry
Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression. (Source: MedWire News - Psychiatry)

Depression May Lower Response to Shingles Vax (CME/CE)
Thu, 14 Feb 2013 18:43:16 +0100 | MedPage Today State Required CME
(MedPage Today) -- Untreated major depression may hamper the protective effect of varicella zoster virus vaccine against herpes zoster -- shingles -- in older individuals, researchers found. (Source: MedPage Today State Required CME)

Study Suggests Link Between Untreated Depression And Response To Shingles Vaccine
Thu, 14 Feb 2013 10:00:00 +0100 | Health News from Medical News Today
Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition caused by the reactivation of the varicella-zoster virus, and more than a million new cases occur each year in the U.S. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition... (Source: Health News from Medical News Today)